These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23318981

  • 21. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J.
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [Abstract] [Full Text] [Related]

  • 22. Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD.
    Lee J, McCulloch CE, Flynn JT, Samuels J, Warady BA, Furth SL, Seth D, Grimes BA, Mitsnefes MM, Ku E.
    Clin J Am Soc Nephrol; 2020 Apr 07; 15(4):493-500. PubMed ID: 32160993
    [Abstract] [Full Text] [Related]

  • 23. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H, Choi HJ, Kang HG, Ha IS, Cheong HI, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS.
    Kidney Blood Press Res; 2017 Apr 07; 42(3):406-415. PubMed ID: 28689198
    [Abstract] [Full Text] [Related]

  • 24. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II, Arodiwe EB, Ijoma CK.
    Ethn Dis; 2006 Apr 07; 16(4):859-64. PubMed ID: 17061738
    [Abstract] [Full Text] [Related]

  • 25. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 Apr 07; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183
    [Abstract] [Full Text] [Related]

  • 27. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC, Chang JM, Yeh SM, Su HM, Chen HC.
    Am J Hypertens; 2013 Feb 07; 26(2):243-9. PubMed ID: 23382409
    [Abstract] [Full Text] [Related]

  • 28. Left ventricular hypertrophy among chronic kidney disease patients in Ghana.
    Amoako YA, Laryea DO, Bedu-Addo G, Nkum BC, Plange-Rhule J.
    Pan Afr Med J; 2017 Feb 07; 28():79. PubMed ID: 29255549
    [Abstract] [Full Text] [Related]

  • 29. Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects.
    Asp AM, Wallquist C, Rickenlund A, Hylander B, Jacobson SH, Caidahl K, Eriksson MJ.
    Clin Physiol Funct Imaging; 2015 May 07; 35(3):223-30. PubMed ID: 24750894
    [Abstract] [Full Text] [Related]

  • 30. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
    Chang JM, Chen SC, Huang JC, Su HM, Chen HC.
    Am J Med Sci; 2014 Mar 07; 347(3):183-9. PubMed ID: 23426086
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E, Mitsis M, Naka KK, Pappas C, Lakkas L, Harisis C, Pappas K, Koutlas V, Tzalavra I, Spanos G, Michalis LK, Siamopoulos KC.
    Transplant Proc; 2014 Nov 07; 46(9):3194-8. PubMed ID: 25420857
    [Abstract] [Full Text] [Related]

  • 33. Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease.
    Zou J, Yu Y, Wu P, Lin FJ, Yao Y, Xie Y, Jiang GR.
    Int J Cardiol; 2016 Oct 15; 221():134-40. PubMed ID: 27400310
    [Abstract] [Full Text] [Related]

  • 34. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
    Cerasola G, Nardi E, Mulè G, Palermo A, Cusimano P, Guarneri M, Arsena R, Giammarresi G, Carola Foraci A, Cottone S.
    Nephrology (Carlton); 2010 Mar 15; 15(2):203-10. PubMed ID: 20470280
    [Abstract] [Full Text] [Related]

  • 35. The CTGF gene -945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes.
    Patel SK, Wai B, Macisaac RJ, Grant S, Velkoska E, Ord M, Panagiotopoulos S, Jerums G, Srivastava PM, Burrell LM.
    Cardiovasc Diabetol; 2012 Apr 26; 11():42. PubMed ID: 22533709
    [Abstract] [Full Text] [Related]

  • 36. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE.
    Atherosclerosis; 2009 Dec 26; 207(2):546-51. PubMed ID: 19524924
    [Abstract] [Full Text] [Related]

  • 37. QTc Interval Prolongation Is Independently Associated with FGF23 and Predicts Mortality in Predialysis Chronic Kidney Disease.
    Sikaneta T, Ho N, Bellasi A, Mahdavi S, Taskapan H, Svendrovski A, Makanjee B, Roberts J, Wu G, Nathoo B, Tam P.
    Cardiorenal Med; 2024 Dec 26; 14(1):45-57. PubMed ID: 37963445
    [Abstract] [Full Text] [Related]

  • 38. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
    Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE.
    Kidney Int; 2002 Aug 26; 62(2):639-47. PubMed ID: 12110029
    [Abstract] [Full Text] [Related]

  • 39. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.
    Zhao X, Zhu L, Jin W, Yang B, Wang Y, Ni M, Zhao Y, Gan L, Zuo L.
    BMC Cardiovasc Disord; 2022 Feb 16; 22(1):55. PubMed ID: 35172749
    [Abstract] [Full Text] [Related]

  • 40. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE, Kutyrina IM, Shvetsov MIu.
    Ter Arkh; 2012 Feb 16; 84(6):21-6. PubMed ID: 22997913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.